Search

Your search keyword '"van der Lei, Susan"' showing total 13 results
Start Over Author "van der Lei, Susan"
13 results on '"van der Lei, Susan"'

2. Recurrent Colorectal Liver Metastases: Upfront Local Treatment versus Neoadjuvant Systemic Therapy Followed by Local Treatment (COLLISION RELAPSE): Study Protocol of a Phase III Prospective Randomized Controlled Trial

Author

Dijkstra, Madelon, Kuiper, Babette I., Schulz, Hannah H., van der Lei, Susan, Puijk, Robbert S., Vos, Danielle J. W., Timmer, Florentine E. F., Scheffer, Hester J., Buffart, Tineke E., van den Tol, M. Petrousjka, Lissenberg-Witte, Birgit I., Swijnenburg, Rutger-Jan, Versteeg, Kathelijn S., and Meijerink, Martijn R.

Published
2024
Full Text
View/download PDF

3. The Added Diagnostic Value of Transcatheter CT Hepatic Arteriography for Intraprocedural Detection of Previously Unknown Colorectal Liver Metastases During Percutaneous Ablation and Impact on the Definitive Treatment Plan

Author

van der Lei, Susan, Opperman, Jip, Dijkstra, Madelon, Kors, Nikita, Boon, Rianne, van den Bemd, Bente A. T., Timmer, Florentine E. F., Nota, Irene M. G. C., van den Bergh, Janneke E., de Vries, Jan J. J., Scheffer, Hester J., Geboers, Bart, Neuss, Timothy, Schouten, Evelien, Lissenberg-Witte, Birgit I., Puijk, Robbert S., and Meijerink, Martijn R.

Published
2023
Full Text
View/download PDF

4. Unresectable Intermediate-Size (3–5 cm) Colorectal Liver Metastases: Stereotactic Ablative Body Radiotherapy Versus Microwave Ablation (COLLISION-XL): Protocol of a Phase II/III Multicentre Randomized Controlled Trial

Author

van der Lei, Susan, Dijkstra, Madelon, Nieuwenhuizen, Sanne, Schulz, Hannah H., Vos, Danielle J. W., Versteeg, Kathelijn S., Buffart, Tineke E., Swijnenburg, Rutger-Jan, de Vries, Jan J. J., Bruynzeel, Anna M. E., van den Tol, M. Petrousjka, Scheffer, Hester J., Puijk, Robbert S., Haasbeek, Cornelis J. A., and Meijerink, Martijn R.

Published
2023
Full Text
View/download PDF

5. MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial

Author

Timmer, Florentine E F, Geboers, Bart, Ruarus, Alette H, Vroomen, Laurien G P H, Schouten, Evelien A C, van der Lei, Susan, Vos, Danielle J W, Dijkstra, Madelon, Schulz, Hannah H, Bakker, Joyce, van den Bemd, Bente A T, van den Tol, Petrousjka M, Puijk, Robbert S, Lissenberg-Witte, Birgit I, de Gruijl, Tanja D, de Vries, Jan J J, Lagerwaard, Frank J, Scheffer, Hester J, Bruynzeel, Anna M E, and Meijerink, Martijn R

Published
2024
Full Text
View/download PDF

6. Tissue Resistance Decrease during Irreversible Electroporation of Pancreatic Cancer as a Biomarker for the Adaptive Immune Response and Survival

Author

Timmer, Florentine E.F., Geboers, Bart, Scheffer, Hester J., Bakker, Joyce, Ruarus, Alette H., Dijkstra, Madelon, van der Lei, Susan, Boon, Rianne, Nieuwenhuizen, Sanne, van den Bemd, Bente A.T., Schouten, Evelien A.C., van den Tol, Petrousjka M., Puijk, Robbert S., de Vries, Jan J.J., de Gruijl, Tanja D., and Meijerink, Martijn R.

Published
2023
Full Text
View/download PDF

7. The Added Value of Transcatheter CT Hepatic Angiography (CTHA) Image Guidance in Percutaneous Thermal Liver Ablation: An Experts’ Opinion Pictorial Essay

Author

Puijk, Robbert S., primary, Dijkstra, Madelon, additional, van der Lei, Susan, additional, Schulz, Hannah H., additional, Vos, Danielle J. W., additional, Timmer, Florentine E. F., additional, Geboers, Bart, additional, Scheffer, Hester J., additional, de Vries, Jan J. J., additional, Smits, Maarten L. J., additional, Bruijnen, Rutger C. G., additional, Deschamps, Frédéric, additional, de Baère, Thierry, additional, Odisio, Bruno C., additional, and Meijerink, Martijn R., additional

Published
2024
Full Text
View/download PDF

8. Local Treatment of Colorectal Liver Metastases in the Presence of Extrahepatic Disease: Survival Outcomes from the Amsterdam Colorectal Liver Met Registry (AmCORE)

Author

Schulz, Hannah H., primary, Dijkstra, Madelon, additional, van der Lei, Susan, additional, Vos, Danielle J. W., additional, Timmer, Florentine E. F., additional, Puijk, Robbert S., additional, Scheffer, Hester J., additional, van den Tol, M. Petrousjka, additional, Lissenberg-Witte, Birgit I., additional, Buffart, Tineke E., additional, Versteeg, Kathelijn S., additional, Swijnenburg, Rutger-Jan, additional, and Meijerink, Martijn R., additional

Published
2024
Full Text
View/download PDF

9. The Added Value of Transcatheter CT Hepatic Angiography (CTHA) Image Guidance in Percutaneous Thermal Liver Ablation: An Experts’ Opinion Pictorial Essay

Author

MS Radiologie, Cancer, Other research (not in main researchprogram), Puijk, Robbert S., Dijkstra, Madelon, van der Lei, Susan, Schulz, Hannah H., Vos, Danielle J.W., Timmer, Florentine E.F., Geboers, Bart, Scheffer, Hester J., de Vries, Jan J.J., Smits, Maarten L.J., Bruijnen, Rutger C.G., Deschamps, Frédéric, de Baère, Thierry, Odisio, Bruno C., Meijerink, Martijn R., MS Radiologie, Cancer, Other research (not in main researchprogram), Puijk, Robbert S., Dijkstra, Madelon, van der Lei, Susan, Schulz, Hannah H., Vos, Danielle J.W., Timmer, Florentine E.F., Geboers, Bart, Scheffer, Hester J., de Vries, Jan J.J., Smits, Maarten L.J., Bruijnen, Rutger C.G., Deschamps, Frédéric, de Baère, Thierry, Odisio, Bruno C., and Meijerink, Martijn R.

Published
2024

11. Efficacy of Thermal Ablation for Small-Size (0–3 cm) versus Intermediate-Size (3–5 cm) Colorectal Liver Metastases: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE)

Author

Dijkstra, Madelon, primary, van der Lei, Susan, additional, Puijk, Robbert S., additional, Schulz, Hannah H., additional, Vos, Danielle J. W., additional, Timmer, Florentine E. F., additional, Scheffer, Hester J., additional, Buffart, Tineke E., additional, van den Tol, M. Petrousjka, additional, Lissenberg-Witte, Birgit I., additional, Swijnenburg, Rutger-Jan, additional, Versteeg, Kathelijn S., additional, and Meijerink, Martijn R., additional

Published
2023
Full Text
View/download PDF

13. Unresectable Intermediate-Size (3–5 cm) Colorectal Liver Metastases:Stereotactic Ablative Body Radiotherapy Versus Microwave Ablation (COLLISION-XL): Protocol of a Phase II/III Multicentre Randomized Controlled Trial

Author

van der Lei, Susan, Dijkstra, Madelon, Nieuwenhuizen, Sanne, Schulz, Hannah H., Vos, Danielle J.W., Versteeg, Kathelijn S., Buffart, Tineke E., Swijnenburg, Rutger Jan, de Vries, Jan J.J., Bruynzeel, Anna M.E., van den Tol, M. Petrousjka, Scheffer, Hester J., Puijk, Robbert S., Haasbeek, Cornelis J.A., Meijerink, Martijn R., van der Lei, Susan, Dijkstra, Madelon, Nieuwenhuizen, Sanne, Schulz, Hannah H., Vos, Danielle J.W., Versteeg, Kathelijn S., Buffart, Tineke E., Swijnenburg, Rutger Jan, de Vries, Jan J.J., Bruynzeel, Anna M.E., van den Tol, M. Petrousjka, Scheffer, Hester J., Puijk, Robbert S., Haasbeek, Cornelis J.A., and Meijerink, Martijn R.

Abstract

Background: Although microwave ablation (MWA) has a low complication rate and good efficacy for small-size (≤ 3 cm) colorectal liver metastases (CRLM), local control decreases with increasing size. Stereotactic body radiotherapy (SBRT) is gaining interest as a potential means to treat intermediate-size CRLM and might be less susceptible to increasing volume. The objective of this study is to compare the efficacy of MWA to SBRT in patients with unresectable, intermediate-size (3–5 cm) CRLM. Methods: In this two-arm, multicentre phase II/ III randomized controlled trial, 68 patients with 1–3 unresectable, intermediate-size CRLM suitable for both MWA and SBRT, will be included. Patients will be treated with MWA or SBRT as randomised. The Primary endpoint is local tumour progression-free survival (LTPFS) at 1 year (intention-to-treat analysis). Main secondary endpoints are overall survival, overall and distant progression-free survival (DPFS), local control (LC) and procedural morbidity and mortality and assessment of pain and quality of life. Discussion: Current guidelines lack clear recommendations for the local treatment of liver only intermediate-size, unresectable CRLM and studies comparing curative intent SBRT and thermal ablation are scarce. Although safety and feasibility to eradicate tumours ≤ 5 cm have been established, both techniques suffer from lower LTPFS and LC rates for larger-size tumours. For the treatment of unresectable intermediate-size CRLM clinical equipoise has been reached. We have designed a two-armed phase II/ III randomized controlled trial directly comparing SBRT to MWA for unresectable CRLM 3–5 cm. Level of Evidence : Level 1, phase II/ III Randomized controlled trial. Trial Registration: NCT04081168, September 9th 2019. Graphical Abstract: [Figure not available: see fulltext.]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results